Meetings

Association of Glycemic Control, Inflammatory Markers and Peri-Operative Complications in Patients Undergoing CABG
Francisco J Pasquel, Priyathama Vellanki, Saumeth Cardona, Isabel Anzola, Maya Fayfman, Limin Peng, Dawn Smiley and Guillermo E Umpierrez

High Dose Vitamin D Supplementation for 12 Months Improves Insulin Sensitivity and Glucose Disposition Indices in African American Men with Hypovitaminosis D and Dysglycemia: Results of the D-Vitamin Intervention in Veteran Administration (DIVA) Randomized Clinical Trial (RCT)
Elena Barengolts, Arfana Kouser, Subhash C Kukreja, Yuval Eisenberg, Irina Ciubotaru and Buvana Manickam

Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Pioglitazone with or without Metformin in Patients with Type 2 Diabetes (T2DM)
Christopher Simon Kovacs, Veeraswamy Seshiah, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans-Juergen Woerle and Uli C Broedl

Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naïve Patients with Type 2 Diabetes (T2DM)
Michael W. Roden, Jianping Weng, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans-Juergen Woerle and Uli C Broedl

Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)
Ludwig Merker, Hans-Ulrich Haering, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Thomas Meinicke, Hans-Juergen Woerle and Uli C Broedl

Deletion of TRAF3 in Myeloid Cells Ameliorates Dietary Insulin Resistance and Glucose Intolerance in Mice
Zheng Chen, Robert Brink and Liangyou Rui

Loss of Sirtuin 4 Leads to Insulin Resistance in Mice
Frank K Huynh and Matthew D Hirschey

Generation and Characterization of Reporter Mice to Monitor Pdx1 and Mafa Promoter Activity
Wataru Nishimura, Nobuaki Funahashi, Haruhide Udagawa, Miho Kawaguchi, Takao Nammo, Hisashi Oishi, Satoru Takahashi and Kazuki Yasuda